|

TORL-4-500 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • TORL Biotherapeutics, LLC1

Indications

  • Liver Disease1
  • Advanced Solid Tumor1
  • Liver Cancer1
  • Hepatocellular Carcinoma1
  • Cancer1

Phoenix, Arizona1 trial

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

Mayo Clinic Phoenix

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.